HEARTSCIENCES INC (HSCS) Forecast, Price Target & Analyst Ratings

NASDAQ:HSCS • US42254E3027

Current stock price

2.57 USD
-0.01 (-0.39%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEARTSCIENCES INC (HSCS).

Forecast Snapshot

Consensus Price Target

Price Target
$10.81
+ 320.70% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2026
EPS Estimate
-$0.87
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.81
Upside
+ 320.70%
From current price of $2.57 to mean target of $10.81, Based on 8 analyst forecasts
Low
$9.29
Median
$10.81
High
$12.60

Price Target Revisions

1 Month
0.00%
3 Months
-21.48%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for HSCS. The average price target is 10.81 USD. This implies a price increase of 320.7% is expected in the next year compared to the current price of 2.57.
The average price target has been revised downward by 21.48% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HSCS Current Analyst RatingHSCS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

HSCS Historical Analyst RatingsHSCS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
HSCS was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HSCS.
In the previous month the buy percentage consensus was at a similar level.
HSCS was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-22Ascendiant CapitalMaintains Buy -> Buy
2025-10-01Ascendiant CapitalMaintains Buy -> Buy
2025-03-18Ascendiant CapitalMaintains Buy -> Buy
2024-12-18Maxim GroupReiterate Buy -> Buy
2024-09-23Ascendiant CapitalReiterate Buy -> Buy
2023-01-30Ascendiant CapitalInitiate Buy
2022-12-19Maxim GroupMaintains Buy
2022-11-09Maxim GroupInitiate Buy
2022-08-08BenchmarkInitiate Speculative Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2026
EPS Estimate
-$0.87
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
66.26%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
59.13%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
HSCS revenue by date.HSCS revenue by date.
5.2K
-63.89%		18.6K
257.69%		4.4K
-76.34%		51K
1,059.09%		1.428M
2,700.00%
EBITDA
YoY % growth
HSCS ebitda by date.HSCS ebitda by date.
-6.086M
-29.97%		-6.278M
-3.15%		-8.315M
-32.45%		-8.543M
-2.74%		-10.619M
-24.31%
EBIT
YoY % growth
HSCS ebit by date.HSCS ebit by date.
-6.113M
-29.80%		-6.306M
-3.15%		-8.353M
-32.46%		-8.938M
-7.01%		-10.621M
-18.83%
Operating Margin
HSCS operating margin by date.HSCS operating margin by date.
-117,557.69%-33,902.15%-189,831.82%-17,525.00%-743.75%
EPS
YoY % growth
HSCS eps by date.HSCS eps by date.
N/A-50.81
35.72%		-9.36
81.58%		-3.80
59.35%		-3.28
13.81%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.87
66.26%		-0.84
55.51%		-0.85
46.42%		-0.91
-6.80%		-0.70
18.82%		-0.57
31.71%
Revenue
Q2Q % growth		51K
1,072.41%
-100.00%		102K
5,000.00%		510K1.02M
1,900.00%
EBITDA
Q2Q % growth		-2.745M
-17.23%		-2.847M
-51.20%		-2.547M
-36.42%		-3.132M
-52.11%		-2.648M
3.53%		-2.292M
19.49%
EBIT
Q2Q % growth		-2.417M
-1.91%		-2.467M
-28.48%		-2.652M
-41.51%		-3.239M
-56.19%		-2.754M
-13.95%		-2.397M
2.85%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HSCS Yearly Revenue VS EstimatesHSCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 500K 1M
HSCS Yearly EPS VS EstimatesHSCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -20 -40 -60

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HEARTSCIENCES INC / HSCS Forecast FAQ

Can you provide the average price target for HEARTSCIENCES INC stock?

8 analysts have analysed HSCS and the average price target is 10.81 USD. This implies a price increase of 320.7% is expected in the next year compared to the current price of 2.57.

Can you provide the consensus estimates for HEARTSCIENCES INC next earnings?

The consensus EPS estimate for the next earnings of HEARTSCIENCES INC (HSCS) is -0.87 USD and the consensus revenue estimate is 0 USD.